| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |